Madrid, Spain

Antonio Romero Garrido

This inventor holds 17 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 8 EPO patents, primarily in Dermatological Treatments. Top assignees: Amderma Pharmaceuticals, LLC, Action Medicines, S.l., Other. Active years: 2011-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antonio Romero Garrido. Retrieved from https://idiyas.com/inventor/antonio-romero-garrido

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17 


 

Average Co-Inventor Count = 6.7

ph-index = 4

Forward Citations = 49(Granted Patents)


Company Filing History:


Years Active: 2011-2019

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Dermatitis
Skin Cancer
Glioma
Rosacea
Hematological Dyscrasias
Ocular Diseases
Arthritis
Angiodependent Diseases
Medicaments
2,5-Dihydroxybenzene
17 patents (USPTO):Explore Patents

Title: **Antonio Romero Garrido: Innovator in Dermatological Treatments**

Introduction

Antonio Romero Garrido, based in Madrid, Spain, is a prominent inventor known for his significant contributions to the field of dermatology. With an impressive portfolio of 17 patents, Garrido has focused much of his research on developing innovative treatments for skin conditions.

Latest Patents

Among his latest inventions are two notable patents centered around the therapeutic applications of 2,5-dihydroxybenzene derivatives. The first patent pertains to the use of these compounds for treating dermatitis, where he outlines the therapeutic and prophylactic benefits of using a 2,5-dihydroxybenzene derivative for combating this common skin ailment. The second patent further expands on this by exploring the use of 2,5-dihydroxybenzene compounds specifically for the treatment of skin cancer, highlighting his dedication to tackling severe dermatological issues.

Career Highlights

Garrido has worked with reputable companies such as Amderma Pharmaceuticals, LLC and Action Medicines, S.L., where he has played a pivotal role in research and development. His efforts in these organizations have propelled advancements in dermatological treatments, underscoring his commitment to improving patient outcomes.

Collaborations

Throughout his career, Garrido has collaborated with notable colleagues, including Guillermo Gimenez Gallego and Serafin Valverde Lopez. These partnerships have enabled him to leverage diverse expertise and insights, contributing to the success of his inventions and patents.

Conclusion

Antonio Romero Garrido stands out as a key figure in skin health innovations. His extensive work with 2,5-dihydroxybenzene derivatives demonstrates his commitment to addressing critical dermatological challenges. As he continues to innovate, the impact of his patents will undoubtedly extend to improving treatments for skin disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…